Ethical Considerations
There are a few ethical considerations involved with a client presenting with impaired
memory due to Alzheimer's disease. As a provider, the client, as well as a family, should be
included in the treatment plan. Risk, benefits, side effects, as well as any changes in the
treatment plan,
should be active communication.
Advanced directives should also be discussed
at the early stages of the disease, if possible.
Also, with the impaired judgment and insight
displayed, providing informed consent is impossible.
The provider must assess the efficacy of
the treatment plan but validating with the caregivers.
Also, it is known Alzheimer’s disease results in a decrease quality of life as well as
physical, emotional, and economic burdens for caregivers. Much of this cost consists of
medications that have some efficacy but limited effectiveness for most patients (Casey et al.,
2010). Providers have a responsibility to their clients as well as family members involved to
discuss all the pros and cons of treatment, including the possible lack of substantial benefit.
Clients and their families should conclude their judgments as to whether to proceed with
pharmacotherapy and the cost associated with it.

RUNNING HEAD: Dementia
7
Conclusion
Due to the impact of Alzheimer’s disease, there is an urgent need for effective therapies.
Unfortunately, there are limited treatment options available. Treatment is aimed at slowing the
progression of the disease
and increasing the client's quality of life.
To achieve compliance with
treatment, one must be aware of complicated dosing regimens, memory impairment, side effects,
as well as the cost of medications. Effective communication should be of importance.

RUNNING HEAD: Dementia
8
References
Alzheimer’s Association. (2019).
What Is Dementia
? Retrieved from
Alzheimers.net. (2019). 2019
Alzheimer’s Statistics
. Retrieved from
Casey, D. A., Antimisiaris, D., & O'Brien, J. (2010). Drugs for Alzheimer's
disease: are they
effective?.
P & T: a peer-reviewed journal for formulary management
,
35(4), 208–211.
Everyday Health. (2018).
What Is Galantamine
? Retrieved from
Folstein, M., Folstein S., & McHugh P. (1975). 'Mini-Mental State': A practical
method for
grading the cognitive state of patients for the clinician
. J Psychiatry
Res,
12:189–198
Heather, J. (2010). FDA allows higher dosage of Aricept for Alzheimer's.
Medical Daily.
Retrieved from -
aricept-
alzheimers-231416
Kerkar, P. (2017). How Effective is Exelon, Know Its Dosage, Side Effects?
Pain Assist
.
Retrieved from -
treatment/medications/how-
effective-is-exelon
Kindly Care. (2018).
Treating Dementia with Aricept (Donepezil).
Retrieved from

RUNNING HEAD: Dementia
9
RxList. (2019).
Aricept
. Retrieved from
Stahl, S. M. (2014b).
The Prescriber’s Guide
(5
th
ed). New York, NY: Cambridge University
Press.

You've reached the end of your free preview.
Want to read all 9 pages?
- Spring '17